Twentyeight-Seven Therapeutics launches to boost anticancer microRNA with small-molecule drugs

Wednesday, September 12, 2018 - 16:30 in Biology & Nature

With $65 million raised, 28-7 is developing inhibitors of the Lin28 protein to boost levels of an anticancer microRNA called let-7

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net